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Abstract.  Brevin is a CaZ+-modulated actin-associated 
protein that will sever F-actin and cap barbed filament 
ends. Limited proteolysis with chymotrypsin or subtil- 
isin cleaves the molecule approximately in half. Cleav- 
age is ~ 10-fold more rapid in Ca  2+ than in EGTA. 
The two fragments are readily separated from each 
other and froI'n undigested brevin by high pressure 
liquid chromatography on a DEAE resin. A 40,000- 
mol-wt fragment from the N-terminal is not retained 
by DEAE, while a 45,000-mol-wt C-terminal fragment 
binds more tightly than brevin. The N-terminal frag- 
ment retains ~10% of the nucleation activity, caps 
barbed ends, and retains 50% of the total severing 
activity defined by dilution induced depolymerization 
of pyrenyl actin, but, in contrast to brevin, none of 
these functions are affected by Ca  2+. Fluorescent actin 
binding studies and gel-filtration demonstrate that the 
40,000-mol-wt fragment binds two actin monomers. 
The 45,000-mol-wt C-terminal fragment has no sever- 
ing, nucleating, or capping activity. Cross-reaction 
with two monoclonal antibodies against two specific 
Ca2+-induced conformations of human platelet gelso- 
lin suggest that both Ca  2+ binding sites are located on 
the carboxyl half of the brevin molecule. One epitope, 
defined as the rapidly exchanging Ca  2+ binding site in 
the gelsolin-actin complex, is lost when a 20,000-mol- 
wt fragment is cleaved from the carboxyl terminal. 
The second epitope, related to the poorly exchanging 
Ca  2+ binding site in the complex, is nearer the middle 
of the brevin molecule. 
ELSOLIN and a  similar plasma protein called  brevin 
(4-8,  15,  18, 20, 23) show Ca2+-modulated interac- 
tions with G  and F-actin. Gelsolin has two  Ca  2÷ 
binding sites (3, 24) and two actin-binding sites (3). Brevin 
has similar properties (4, and unpublished data). Under non- 
polymerizing conditions, gelsolin will form a tight complex 
with two actin monomers and two calcium ions. Lowerinl~ 
the Ca  2÷ concentration with EGTA reduces the affinity fo) 
one actin and one Ca  2+. These can then be removed by gel 
filtration or centrifugation. The  other actin  molecule and 
Ca  2÷ ion are trapped on gelsolin  (3)  or brevin and can be 
isolated as a complex. The estimated half-time for dissociation 
of the  brevin-actin-Ca  2+  complex in  EGTA  is  -30-35  d 
(Sedlar,  P.  A.,  and J.  Bryan, unpublished data).  We have 
arbitrarily termed  the  non-exchangeable site  as  site  I  and 
distinguish an actin site I and a Ca  2+ site I from their more 
rapidly exchanging site II counterparts. Gelsolin will sever F- 
actin filaments (2,  1  l, 20, 25), will nucleate the assembly of 
G-actin (I l, 14, 17, 20, 21), and cap barbed filament ends (2, 
20, 21). Which sites are involved in severing and capping is 
not yet clear. Recently we have demonstrated that the gelso- 
lin-actin complex, GA,CA2,  with actin site I occupied will 
cap, but not sever actin filaments, and have presented evi- 
dence that free gelsolin (GCa2) does not readily cap barbed 
ends (2). In this paper we begin to explore the inter-relation- 
ships between actin and Ca  2÷ sites I and II and relate these to 
capping and severing activities  using protease digestion  and 
conformation specific monoclonal antibodies. 
We have defined two monoclonal antibodies against human 
platelet gelsolin  that recognize  conformational changes in- 
duced by Ca  2+ binding (9). 4F8 IgA appears to recognize an 
epitope induced when the non-exchangeable site (I) is occu- 
pied; 8G5 IgG appears to recognize an epitope induced when 
the exchangeable  site (II) is occupied. We demonstrate here 
that human brevin has a  protease-sensitive  region near the 
middle of the molecule. Subtilisin  and chymotrypsin both 
cleave Ca  2+ liganded brevin to produce two fragments with 
apparent molecular weights of -40,000 and 45,000. The two 
fragments can be readily separated by DEAE chromatogra- 
phy.  The  40-kD  fragment is  less acidic and elutes  before 
brevin, whereas the 45-kD fragment is more tightly bound to 
DEAE. The actin binding activity is on the 40-kD fragment, 
which is derived from the amino terminal half of the protein. 
The 40-kD fragment retains a large fraction of the original 
severing activity, but proteolytic cleavage of the parent mol- 
ecule eliminates the Ca  2+ sensitivity of the filament severing 
reaction. The Ca2+-induced epitopes are both on the 45-kD 
fragment from the carboxyl half of the  molecule.The 4F8 
epitope is nearer the center of the molecule, whereas the 8G5 
epitope is on a terminal 20-kD fragment at the carboxyl end. 
© The Rockefeller  University Press, 0021-9525/86/04/1439/18 $1.00 
The Journal of Cell Biology, Volume 102, April 1986,  1439-1446  1439 Materials and Methods 
Protein Purification 
Brevin was immunopurified  from pooled human sera following the procedures 
outlined  in  Hwo and  Bryan (9). Monoclonal  antibodies  were isolated from 
serum-free harvest fluid. The purification and characterization  of4F8 IgA and 
8G5 IgG are given in Hwo and Bryan (9). Actin was prepared  according to 
Spudich and Watt (16) and labeled with pyrene iodoacetamide as described by 
Bryan and Coluccio (2). Protein determinations  were done by the method  of 
Bradford  (l).  The  brevin  concentration  was estimated  using  an  extinction 
coefficient of 150.000/M per cm determined for bovine brevin (10). 
Fluorescence Measurements 
Dilution  induced  depolymerization  experiments  using  pyrene  F-actin  were 
done  as described by Bryan and Coluccio (2). Actin  monomer binding  was 
measured  using NBD(nitrobenzoxadiazole)l-actin  as described by Bryan and 
Kurth (3). Pyrene actin excitation and emission wavelengths were 365 and 407 
nm, respectively; NBD-actin excitation  and emission wavelengths were 475 
and 530 nm, respectively. 
SDS Gel Electrophoresis and Immunoblotting 
SDS gel electrophoresis was done as outlined by Laemmli (13). Immunoblots 
were performed as described by Towbin  et al. (19) modified  as described by 
Hwo and Bryan (9). 
Sequencing of Peptides 
A model 470A gas phase sequencer (Applied Biosystems, Inc., Foster City, CA) 
was used for all analyses. PTH amino acids were identified by high pressure 
liquid chromatography  (HPLC) using a  Beckman model  344 chromatograph 
equipped with two model  112 pumps and two model  160 detectors (Beckman 
Instruments,  Inc., Palo Alto, CA). Samples were automatically injected using a 
model M710B Waters Intelligent Sample Processor (WISP, Waters Instruments, 
Rochester, MN). PTH amino acids were analyzed using a 5-urn pore size IBM 
cyano column (4.5 mm x  25 cm) (IBM Instruments, Inc., Danbury, CT) with 
either a DuPont ETH guard column or a pellicular CN guard column (DuPont 
Co, Wilmington,  DE). The samples were analyzed at 35"C using a gradient 
system that consisted of buffer A (0.02 M sodium acetate, 5% tetrahydrofuran, 
pH 5.95 and  17 ul of HPLC grade acetone/liter)  and buffer B (acetonitrile). 
The PTH amino acids are eluted by increasing buffer B from  11% to 45% at 
2% per minute at a flow rate of I ml/min. 
HPLC Fractionation 
Brevin and brevin digests were fractionated  using a Waters HPLC apparatus. 
DEAF chromatography  was done on a Waters DEAE-5PW column,  0.75  × 
7.5 cm. The flow rate was 1 ml/min. The solvent was 25 mM Tris-HCl, pH 
7.0. 0.1  mM EGTA. A gradient from 0 to 0.4 M NaCI was developed over 30 
rain; 0.5-ml fractions were collected and analyzed for protein by Bradford assay 
( 1  ), by SDS gel electrophoresis, and using various functional assays as described 
in the text. 
Gel  filtration  was done  using  Waters  Protein  Pak  300SW and  ~251 gel- 
filtration columns in tandem.  10-50-ul samples at 0.5-2 mg/ml were injected. 
The flow rate was  1 ml/min. The solvent was 0.1  M sodium phosphate,  pH 
7.0. The columns were calibrated  using various molecular weight standards, 
which include beta-galactosidase, 520,000; ferritin, 440,000; catalase, 232,000; 
phosphorylase.  94,000;  bovine  serum  albumin  (BSA), 67,000;  ovalbumin, 
43,000 and carbonic anhydrase, 30,000. 
Protease Cleavage 
Brevin  at  1 mg/ml  was cleaved  with  bacterial  subtilisin  (type  VII,  Sigma 
Chemical  Co.,  St.  Louis,  MO) or Na-p-tosyl-L-lysine  chloromethyl  ketone- 
treated chymotrypsin (type VII, Sigma Chemical Co.) using various conditions 
as indicated in the figure legends. The buffer used was 10 mM Tris-HCl, 0.5 
mM CaCI2, 1 mM NAN3, pH 8.0 at a temperature  of 20"C. The reaction was 
stopped by addition of EGTA to 1 mM and diisopropylfluorophosphate (DIFP) 
to 5 mM. The DIFP was stored as a 200 mM stock solution in propylene glycol 
at -20"C. 
' Abbreviations  used in  this paper: DIFP, diisopropylfluorophosphate;  HPLC, 
high pressure liquid chromatography~ NBD, nitrobenzoxadiazole. 
Results 
The results of one experiment in which brevin was digested 
with subtilisin at a weight ratio of 1:100 enzyme/brevin are 
shown  in  Fig.  1 a.  At  early times the  two  major cleavage 
products are $45  and $40,  45- and 40-kD polypeptides, re- 
spectively. These are then cleaved into two slightly  smaller 
polypeptides; $45  yields  $44  and  $40  yields  $38.  We  see 
similar results (Fig.  1  b) using chymotrypsin at 1:100 enzyme/ 
brevin (wt/wt) concentrations. Cleavage products, CT45 and 
CT40, are produced at early digestion times that have molec- 
ular weights -45,000 and 40,000.  At later times the 45-kD 
fragment is cleaved to a 43-44-kD fragment, and the 40-kD 
fragment is cleaved to pieces with apparent molecular mass 
of ~30 and 15 kD. Ca  2÷ liganded brevin is more accessible to 
both subtilisin and chymotrypsin. For comparison, the partial 
results from one experiment using chymotrypsin in the pres- 
ence of EGTA are  also shown  in  Fig.  l c.  Comparing the 
extent of hydrolysis at various times, we estimate that Ca  2+ 
liganded brevin is about 10 times more sensitive to proteolysis 
than  the  unliganded  form.  Experiments  using  BSA  as the 
protease substrate show that neither chymotrypsin nor subtil- 
isin have intrinsic calcium sensitivity. 
Immunoblotting with 4F8 IgA and 8G5 lgG shows that the 
epitopes recognized by both monoclonal antibodies are on 
the 45/43-kD fragments. Selected lanes from the gels in Fig. 
1  are  shown  in  Fig.  2.  More  pronounced  proteolysis  by 
subtilisin generates smaller fragments of $44  each of which 
has only one of the epitopes. $34 is the smallest fragment we 
have identified that binds to 4F8 IgA, and $37 is the smallest 
that is recognized by 8G5 IgG (data not shown). Monoclonal 
antibody binding to all of the fragments is strictly dependent 
upon the presence of calcium. 
Fig. 2 shows data that place the 8G5 epitope on one end of 
the brevin molecule. In some preparations we see a proteolytic 
fragment with a  molecular weight of ~70,000-75,000.  This 
fragment cross-reacts strongly with 4F8 IgA, but not with 8G5 
IgG, indicating that the 8G5 epitope is on the missing 20-kD 
fragment. 
Separation of Brevin Fragments 
by DEAE-Chromatography 
Brevin and the 40- and 45/43-kD fragments are readily sep- 
arated by DEAE-chromatography. Fig.  3 a shows the resolu- 
tion of a chymotrypsin digest of 3 mg of brevin. CT40 is not 
retained by the DEAE column in 25 mM Tris-HC1, 0.1  mM 
EGTA, pH 7.4 at 2.5-5 min. Brevin elutes at 0.19 M at ~29- 
30  min, and CT45/43  elutes at 0.24  M  NaC1 at ~34  min. 
The results suggest that one half of the brevin molecule, the 
45-kD fragment, is considerably more acidic than the other 
half. Fig.  3 b  illustrates the purity of the three major peaks 
and shows the cross-reactivity with the two monoclonal anti- 
bodies. 
Sequence Data 
We have placed the 40-kD fragment on the amino half of the 
parent brevin molecule by sequencing a small fraction of $38 
which is derived from this polypeptide. The results are shown 
in  Scheme I. The  $38  sequence begins with  residue  24  of 
brevin (22). For this sequencing we used a preparation that 
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Figure 1. Proteolysis of brevin. Panel a illustrates the digestion of human brevin using bacterial subtilisin at a 1:100 wt/wt ratio. The enzyme 
was added and the reaction stopped by addition of EGTA to 1 mM and DIFP to 5 mM at various times. The first lane contains marker proteins 
with  known  molecular  weights; phosphorylase  b,  94,000;  BSA, 67,000;  ovalbumin,  45,000;  carbonic  anhydrase,  30,000; soybean  trypsin 
inhibitor,  21,000; and lysozyme, 14,300. The digestion times were 0, 5, 10, 15, 20, 30, 45, and 60 min in lanes 2-9, respectively. There is an 
accumulation of four peptides. Panel b illustrates a similar digestion using chymotrypsin at a 1:100 wt/wt ratio. From left-to-right the reaction 
times were 0, l, 3, 5, 10, 30, 60, 90, and 120 rain. At early times we see predominately two peptides with apparent molecular weights of 40,000 
and 45,000. The 45,000 species gives rise to a third peptide at 43,000; the 40,000 species gives rise to one at about 38,000 that is progressively 
degraded to fragments of-30,000-31,000 and  15,000. Panel c shows a  120-rain digestion time point with chymotrypsin  in the presence of 
EGTA. Compare with the last lane in b. Solution conditions:  l0 mM Tris-HCl, 0.5 mM CaCl~, 1 mM NAN3, pH 8.0 for the digestions in a 
and b. The digestion in c was done in the same buffer plus 2 mM EGTA. The brevin concentration  was 1 mg/ml in each digestion mixture; 
the temperature  was 20"C. 
was greater than  90%  pure  $38.  Although we have  not se- 
quenced $40,  we make the tentative  conclusion that $38  is 
generated from $40 by cleavage at residue 24. 
Activity  of Cleaved Products 
To  estimate  the  activity  of the  fragments  relative  to intact 
brevin, we have compared the severing activity of brevin with 
an unfractionated mixture of polypeptides from a  subtilisin 
digest equivalent to the 30-min time point shown in Fig.  1 a, 
lane  7. The results are shown in Fig. 4 a.  Equal amounts of 
brevin were present in the digested and undigested samples. 
A  20-ul aliquot of pyrene-F-actin at  3 uM was diluted  into 
1,500 #1 of 100 mM KCI, 3 mM MgC12, 0.5 mM ATP, 2 mM 
Tris-HC1, pH 8, to a final actin concentration of 40 nM. The 
EGTA samples  contained  1 mM  EGTA; the  Ca  2÷  samples 
contained 0.2  mM  CaCI2.  The brevin  samples  contained  1 
nM  undigested  brevin;  the  digested  samples  contained  an 
equivalent amount of  digested brevin. In the presence of  Ca  2+, 
brevin markedly increases the rate of depolymerization (open 
triangles).  This  effect  is  attenuated  8-to-9-fold  in  EGTA 
(closed triangles) and  closely resembles the control without 
added brevin (circles).  The digested brevin retains a substan- 
tial  severing activity in  Ca  2÷  (open  squares)  and  shows  no 
modulation  upon  reducing  the  Ca  2÷  concentration  (filled 
squares).  It  is  difficult  to  quantitate  the  severing  activity 
precisely, but the initial rate ofdepolymerization with digested 
brevin is approximately one-half that of the parent molecule. 
A  similar  result  is  seen  for  nucleation.  Fig.  4b  shows  the 
results of  initiating assembly of 5 uM actin (5 % pyrene-labeled 
actin, 95% unlabeled actin) in the presence of 50 nM brevin 
or an  equivalent  amount  of digested  brevin.  The degree of 
brevin digestion was equivalent to that used in the severing 
experiment.  Brevin nucleates rapid assembly in the presence 
of Ca  2÷ (open triangles)  and,  under these  conditions,  slows 
assembly in the presence of EGTA (closed triangles). Digested 
Brevin 
Brevin 
$38 
10 
ALA-THR-ALA-SER-ARG,GLY-ALA-SER-GLN-ALA- 
20 
GLY-ALA-PRO-GLN-GLY-ARG-VAL-PRO-GLU-ALA- 
XXX-PRO-ASN- 
30 
XXX-MET-VAL-VAL-GLU-HIS-PRO-GLU-PHE-LEU-LYS-ALA- 
XXX-MET-VAL-VAL-GLU-XXX-PRO-GLU-PHE-XXX-LYS-ALA. 
Scheme L Comparison of amino terminal sequence for brevin and $38. 
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specific monoclonal antibodies . Panels a and b show immunoblots
stained using 8G5 IgG and 4F8 IgA, respectively . The gels are from
lanes 3-7 ofthe chymotrypsin digest shown in Fig . 1 b. Both antibod-
ies recognize the 45,000- and 43,000-mol-wt fragments, but not the
40,000-mol-wt fragment, whose position is indicated by the open
arrow . Lane 1 in c shows the Coomassie Blue profile of a brevin
preparation with a 75,000-mol-wt peptide, U75, marked by the small
arrow, that is produced by an unknown protease in our preparations.
This peptide reacts strongly with 4F8 IgA in lane 2, c, but not with
8G5 IgG in the last lane . We infer that the 8G5 epitope is on a
15,000-20,000-mol-wt piece at one end ofthe brevin molecule . The
larger arrowhead marks the position of the parent brevin molecule .
brevin shows some nucleation in both Ca2' and EGTA with
no apparent modulation . The initial rate of assembly of the
samples with digested brevin was 10-12% of the control
brevin rate in calcium . Both the digested and undigested
molecules appear to cap the barbed filament ends as shown
by a reduction in the final fluorescence values . The effective
nucleation by the brevin digest is strongly dependent upon
the concentration used . At low concentrations, less than 1
digested brevin per 100-200 actin molecules, we see a decrease
in the rate of assembly compared with controls, similar to
that observed with gelsolin and gelsolin-actin complexes (11).
We interpret this as capping of some of the barbed ends with
an apparent decrease in the overall rate of polymerization .
Higher concentrations of the active fragment(s) increase the
apparent rate of assembly above the control rate. The control
polymerization curve in EGTA has been omitted for clarity,
but lies between the brevin plus Ca2+ curve and the brevin
digest values .
Identification ofthe MajorSevering Fragment
The severing activity of the DEAE purified chymotryptic
fragments is shown in Fig . 5 . The open circles show the
depolymerization of the control F-actin diluted to 40 nM.
Intact brevin at 1 .5 nM in the presence of Ca2+ increases the
rate of depolymerization -25-fold (open triangles), but has
little effect in EGTA (data not shown) . The 40-kD fragment,
at 1 .5 nM, increases the rate of depolymerization -12-fold
(open squares), about one-half the value for brevin . The
activity of the purified 40-kD fragment shows no attenuation
in 1-10 mM EGTA (filled squares) . The 45/43-kD piece has
no detectable effect at 15 nM, 10 times the concentration of
the 40-kD fragment as shown by the closed circles that are
equivalent to control values.
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Figure 3 . Fractionation of a brevin digest by DEAE ion-exchange
chromatography . 3 mg of brevin were digested with 30 jug of chy-
motrypsin for 10 min at 20°C. The reaction was stopped by addition
ofEGTA to 1 mM and DIFP to 5 mM . The brevin concentration
was 6 mg/ml in 10 mM Tris-HCI, 0 .5 mM CaC12,pH 8.0 with 1 mM
NaN 3 . The sample was applied to a WatersDEAE-5PW column and
eluted with a NaCl gradient of 0.01 M/min . The flow rate was 1 ml/
min . 0.5-ml fractions were collected and analyzed for protein using
the Bradford assay . The protein profile is shown in a . Three major
fractions were observed corresponding, as shown in b in order of
elution, to the 40-kD protein, brevin, and the 45-kD protein . Fig. 3 b,
panel a shows the Coomassie Blue staining profiles for the 2 .5-, the
29.5-, and the 34-min fractions. Panel b shows the same fractions
blotted with 4F8 IgA, and panel c shows the same fractions blotted
with 8G5 IgG .
Identification and Characterization ofActin
Binding Fragments
We have used three approaches to identify and characterize
further the half of the molecule that binds actin : chromatog-
raphy of digests on DNAse I-Sepharose, reconstitution of
fragments with actin followed by gel-filtration, and enhance-
ment of NBD-actin fluorescence . Chromatography on
DNAse I was done by adding G-actin to the DIFP-inactivated
digestion mixture at 2 mol of actin per mole of brevin,
incubating for 30 min at 4°C, and chromatographing on
DNAse I-agarose as described by Wang and Bryan (20) . The
45/43-kD fragments, from either a subtilisin or a chymotryp-
sin digest, are not retained at high or low ionic strength, in
the presence or absence of calcium, or in the presence or
absence of magnesium . An EGTA wash, which normally
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Figure  4.  Assay  of the  severing and  capping  activities of brevin 
proteolytic digests.  The activity of a 30-rain subtilisin digest equiva- 
lent to that shown in lane 7 of Fig. 1  a was assayed  for its effects on 
dilution  induced  depolymerization  of F-actin  (a)  and  on  G-actin 
polymerization (b).  In a, the effect of l  nM brevin in CaCI2 (A) or 
EGTA (&) is compared with either  l  nM digested brevin in CaCl2 
(lq),  in  EGTA (I)  or with  buffer alone  (©). The initial rates  are 
~0.045, 0.16, and 0.32 fluorescence units s  -~ for control or brevin in 
EGTA, for brevin digests,  and for brevin in CaC12, respectively. In 
each experiment, 3 #M pyrene actin,  100% labeled, was diluted to a 
final concentration of 40 nM into 2 mM Tris-HC1,  100 mM KCI, 3 
mM MgC12, 0.5 mM ATP, 0.2 mM CaCI2 at pH 8.0 plus the added 
proteins. The EGTA samples also had 2 mM EGTA. In b, 5 vM G- 
actin, 5% pyrene-labeled, was assembled by addition of KCl to  100 
mM and MgC12 to 3 mM in the presence of digested or undigested 
brevin and either 0.2 mM CaCl2 or 2 mM EGTA. ©, control assembly 
in 0.2 mM CaCI2; A, undigested brevin in 0.2 mM CaCI2; A, undi- 
gested brevin in 0.2 mM CaCl2 plus 2 mM EGTA; I-q, digested brevin 
in 0.2 mM CaCl2; and I,  digested brevin in 0.2 mM CaC12 plus 2 
mM  EGTA.  The control  assembly in 0.2  mM  CaC12 plus 2  mM 
EGTA is omitted for clarity, but lies between the brevin plus Ca  2÷ 
data and the 40-kD fragment values. The brevin concentration, either 
digested or undigested, was 50 nM. The temperature was 20"C. 
removes  gelsolin-actin  (20)  or  brevin-actin  complexes 
(Bryan, J., and S. Hwo, unpublished data),  does not remove 
protein. Actin and 40-kD fragments are released using either 
3  M  quanidine-HC1  or  0.1  M  glycine-HCl,  pH  2.8.  We 
conclude that the 40-kD fragment is the actin binding half of 
the brevin molecule.  After either quanidine or low pH treat- 
ment, the actin can be separated  from the 40-kD fragment by 
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Figure 5. The amino terminal half of the brevin molecule severs F- 
actin and is not Ca  2+ regulated. The severing activity of the DEAE 
purified 40- and 45-kD fragments was assayed as described in Fig. 
4a. The results for the 40-kD fragment from the amino terminal, at 
1.5 nM, are shown by the squares. F-I, data from an experiment using 
0.2 mM CaC12; I,  data obtained using 0.2 mM CaCI2 plus 2  mM 
EGTA. We see no difference plus or minus Ca  2+. A, brevin control 
data, 1.5 nM, plus 0.2 mM CaCI2. The brevin control data plus EGTA 
have been omitted for clarity, but fall on the F-actin control depolym- 
erization curve (O). II, data for depolymerization in 15 nM of the 45- 
kD  fragment  from  the  carboxyl terminal  in  0.2  mM  CaC12. The 
results in 2 mM EGTA are equivalent. The solution conditions are 
the same as those given in Fig. 4a. 
dialysis to lower the salt concentration  followed by chroma- 
tography  on  DEAE-Sephacel  or on  DEAE  using  HPLC  as 
shown  in  Fig.  3.  Depolymerization  experiments  show  that 
$40  or CT40  purified  by actin-DNAse  I  and  DEAE chro- 
matography  severs F-actin about  as efficiently as the DEAE 
purified material (data not shown). 
Number of  Actin Binding Sites on the 
40-kD Fragment 
Reconstitution experiments give a more quantitative estimate 
of the number of actin molecules bound per 40-kD fragment. 
We have shown previously that an NBD-actin bound at actin 
site I on gelsolin has the same fluorescence  quantum yield as 
NBD-G-actin, but an NBD-actin bound at actin site II has 
approximately a 2.5  times greater quantum yield  similar to 
NBD-F-actin (3). Fig. 6a shows a titration curve for brevin 
in the presence of 0.2 mM CaC12. An extrapolation of a least 
squares line through the first three data points to the intercept 
with a horizontal line through the plateau gives a value of 1.8 
molecules of actin bound per  molecule of brevin.  Fig.  6 b 
shows the normalized binding curves for brevin and the 40- 
kD fragment in both Ca  2+ and EGTA. The brevin and 40-kD 
protein values were determined by the Bradford dye binding 
assay  or using the  extinction  coefficient  for bovine brevin 
(10). The curves for both brevin and the 40-kD fragment are 
quite similar;  the striking  difference  is that the 40-kD-actin 
interaction is not Ca  2+ regulated.  A similar extrapolation of 
the initial  binding data for the 40-kD fragment gives a value 
of 2.4 actin molecules bound/40-kD fragment. The reasons 
for the somewhat higher value are unclear, but could be due 
to differences  in dye binding or extinction coefficient  for the 
whole versus part of the molecule. 
Complex formation was  also  examined  using HPLC gel 
filtration.  The results  for CT45/43 are summarized in  Fig. 
7a. We see no evidence for actin-45/43-kD fragment inter- 
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Figure 6.  Titration of actin-binding sites on brevin and the 40-kD 
fragment  using NBD-actin.  (a)  Titration of  100  nM  brevin with 
NBD-actin.  Aliquots of NBD-actin  in  2  mM  Tris-HCl,  0.2  mM 
CaC12, 0.5 mM ATP at pH 8.0 were added to  100 nM brevin in the 
same buffer plus 2  mM  MgC12 (k) or to the buffer alone (A). The 
brevin samples show a  fluorescence increase equivalent to that de- 
scribed previously for geisolin (3).  The difference binding curve is 
given by the open circles and shows saturation at ~ 1.8 actin molecules 
per brevin. For a different preparation of brevin this estimate has a 
range of 1.8-2.2 actin molecules/brevin. (b) Binding data for brevin 
and the 40-kD fragment are compared. The 40-kD fragment gives an 
extrapolated value of 2.4 actin molecules per 40-kD fragment. The 
data are normalized to percent of maximum binding given by fluo- 
rescence/maximum  fluorescence for each  sample  and are  plotted 
versus the number of actin  molecules added per protein. O, brevin 
plus  0.2  mM  CaCl2; O,  are  for brevin  plus  2  mM  EGTA.  The 
corresponding  40-kD  data are  given (A  and &).  The brevin  plus 
EGTA dam were calculated using the maximum fluorescence value 
obtained  for brevin  plus  Ca  2÷.  Sample  additions  were  made  and 
fluorescence measurements taken after 15-20 rain at 20*(?. 
actions in the presence or absence of Ca  2÷, using either 0.1  M 
sodium phosphate, pH 7.0 or 0.15 M NaC1,  10 mM Tris-HCl, 
pH  7.5.  Fig.  7 b illustrates  the results using CT40.  We  find 
complex formation in both Ca  2÷ and EGTA and have esti- 
mated the stoichiometry of binding by estimating the Stokes 
radius of the complex by comparison of the elution time with 
elution times for proteins of known Stokes radii. The Stokes 
radius  of the  CT40-actin  complex  is  that  expected  for  a 
protein of ~ 125,000 mol wt. In four separate determinations 
the  range  of values  was  125,000-I 35,000,  which  indicates 
that there are two actin molecules bound to one CT40 frag- 
ment.  This  complex  is  formed  in  either  Ca  2÷-  or  EGTA- 
containing buffers. 
Discussion 
The data show that the brevin molecule is organized into two 
approximately  equal  size domains  that  are  separated  by a 
protease-sensitive region. The conformation of the protease- 
sensitive region is Ca  2÷ sensitive and is about  10-fold more 
accessible to either subtilisin or chymotrypsin when brevin is 
liganded with Ca  2÷. Both chymotrypsin and subtilisin release 
a 40-kD fragment that protein sequencing places on the amino 
terminal half of the molecule. The reconstitution studies and 
fluorescence measurements  show  that  the  40-kD  fragment 
contains both actin binding sites.  The Ca2÷-sensitive  epitopes 
recognized by the monoclonal antibodies are on the carboxyl 
half of the molecule, and from the immunoblot data we have 
concluded that the 8G5 epitope is on a 20-kD fragment near 
the carboxyl terminal.  The actin binding domain is defined 
by retention on DNASe I-agarose as a complex with actin, by 
its ability to increase the fluorescence of NBD-G-actin, and 
by its severing, capping, and nucleating activities.  The Ca  2÷ 
regulatory domain  is defined by two conformation specific 
monoclonal antibodies that do not react with the actin binding 
fragment. 
The fact that the actin binding domain retains a significant 
fraction of its severing, capping, and nucleation activities, but 
is unaffected by Ca  2÷, shows that Ca  2÷ binding is not required 
to induce a brevin conformation that will interact with actin. 
The  reverse  appears  to  be  the  case,  the  40-kD  fragment 
appears to have constitutive severing and capping activity that 
is inhibited in the whole molecule at low Ca  z÷ concentrations. 
Ca  :÷ binding appears to induce a conformation change that 
makes these binding sites accessible to actin. Cleavage with 
subtilisin separates the actin binding domain from the inhib- 
itory  Ca  2÷  regulatory  domain  and  also  makes  these  sites 
accessible. 
Kwiatkowski et at.  (12) have reported on the isolation of 
actin binding domains from brevin using chymotrypsin diges- 
tion. They have focused on CT17, a  17K fragment from the 
amino terminal end of the brevin molecule, that binds to G- 
actin-agarose and retains  -1%  of the severing activity. We 
assume, but have not specifically demonstrated,  that this is 
the 15-17-kD fragment that appears later in our chymotrypsin 
digests.  We  have  isolated  a  similar  17-kD  fragment  from 
trypsin  digests that  retains  severing activity and  have  used 
monoclonal antibodies to show this comes from the amino 
terminal of the 40-kD fragment. Kwiatkowski et al. (12) also 
describe a set of internal peptides, CT52 and CT47, that bind 
to G-actin in Ca  2÷, but not EGTA, and CT47 has no severing, 
capping, or nucleating activity. We see no similar major actin- 
binding fragments in our chymotrypsin digests and note that 
the 45-kD fragments from the carboxyl half of the molecule 
do not interact with actin. 
In Fig.  8,  we  have  diagrammed  the  organization  of the 
various peptides. We have defined the order of the two Ca  2÷ 
sites by the following observations. CT40 and $40 are located 
at the N-terminus and do not react with either antibody. $45/ 
43 and CT45/43 contain both epitopes. The cleavage product, 
U75,  from  an  unknown  protease,  in  some  of our  brevin 
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Figure  7.  Formation of actin-brevin fragment complexes. G-actin at a final concentration of 0.2 mg/ml was mixed with either the 45-kD 
carboxyl terminal fragment at a final concentration of 0.2 mg/ml (a) or the 49-kD amino terminal fragment at a final concentration of 0.2 
mg/ml (b) and incubated for 5 rain at 20°C. 25-pi samples of the 2: I  actin/fragment mixtures were injected onto a Waters  I  125 column in 
tandem with a Waters 300 SVv" column equilibrated with 0. l  M  sodium phosphate at pH 7.0. The flow rate was 1.0 ml/min at 20°C. In each 
panel, curve a is from the G-actin standard. The peak at ~16.5 rain is O-actin, the second peak at 22.5 rain is from ATP. Curve b is for either 
the 45-kD fragment (panel a) or the 40-kD fragment (panel b). The c curves are for the mixtures. There is no shift in elution position for the 
actin +  45-kD mixture, but the actin +  40-kD mixture gives a more rapidly eluting complex with a larger Stokes radius and an apparent 
molecular weight of 125,000 when compared with standard proteins of known Stokes radius and molecular weight. Four determinations gave 
a range of 125,000-135,000-mol-wt. We see the same result with the 40-kD fragment +  actin in the presence  of 2 mM EGTA. The optical 
densities at 214 nm are arbitrary and have been scaled to allow the curves to be placed over one another. Similar results were obtained using 
I0 mM Tris-HC],  150 mM NaCI, 0.2 mM CaCI2, pH 7.5 as the equilibrating buffer with and without 2 mM EOTA. In this buffer, however, 
we find that brevin interacts to some degree with the resin in the separating columns. 
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Figure  8.  Diagram of brevin functional domains. This is a schematic 
representation of the functional domains of the brevin molecule. The 
arrows indicate sites of protease sensitivity for chymotrypsin, subtili- 
sin, and an unknown protease. Sequencing places the 40,000-mol-wt 
fragment with severing/capping activity at the amino terminal. We 
locate Ca site It, the exchangeable Ca  2÷ site, on the carboxyl terminal 
using the 8G5  IgG monoclonal antibody that binds to brevin and 
gelsolin or their corresponding actin complexes only if Ca  2÷ is present. 
Ca site I, the non-exchangeable site in gelsolin-actin and brevin-actin 
complexes, was located using the 4F8 IgA monoclonal antibody that 
preparations,  reacts with  4F8  IgA, but  not  8G5  IgG. This 
places at least part of the 8G5 epitope, within  18-20 K of the 
C-terminus.  Using  functional  criteria,  8G5  appears  to  be 
associated with Ca site II, the exchangeable Ca  2+ binding site 
(9). The non-exchangeable site, Ca site I, must be nearer the 
center of the molecule and is clearly placed on CT45/43. On 
immunoblots,  CT45/43  reacts  strongly with  4F8  IgA.  We 
cannot unequivocally decide which actin binding site corre- 
sponds to site I, the non-exchangeable site.  On the basis of 
proximity to the 4F8  epitope, we  suggest  that the  interior 
actin binding site corresponds to site I. 
binds to brevin-actin complexes even in EGTA.  We have ordered 
actin sites I and II arbitrarily and propose that actin site I is located 
close to Ca site I. Furthermore, we infer that Ca site II and actin site 
II must be folded into close proximity if the carboxyl portion of the 
molecule is to inhibit severing in the absence of Ca  2+. 
Bryan and Hwo Actin and Ca  2+ Domains  in Brevin  144:5 We infer that Ca site II and actin site II must be in close 
proximity if the carboxyl part of the molecule is to inhibit 
actin-brevin interactions in the absence of Ca  2÷. In support 
of this, we have preliminary evidence that the 75,000-mol-wt 
fragment, U75,  missing only Ca site II,  actively severs fila- 
ments  in  EGTA.  Finally,  we  have  some  evidence  that  a 
70,000-75,000-mol-wt  trypsin  fragment,  missing  only  the 
amino terminal, will cap but not sever filaments. 
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